Built from live FDA enforcement data analysis
⏰ QMSR deadline: Feb 2, 2027 — Are you ready?
Trusted by 500+ medical device companies

Biocompatibility & TRA Toolkit: ISO 10993 Biological Evaluation Templates

Biocompatibility and TRA Toolkit — biological evaluation plan, toxicological risk assessment, chemical characterization report, test selection justification, BER summary, and FDA submission checklist.

$2776+$347

Save 88% vs hiring a consultant

A consultant would charge $2,776+ for this documentation. Get it instantly for $347.

🛡️

7-Day Iron-Clad Guarantee

Download everything. Review every template. If it doesn't save you at least 40 hours of documentation work, email us for a full refund. No questions. No hassle.

Every week without proper documentation is another week of audit exposure.

The Audit-Ready Guarantee:7-day full refund if not 100% satisfied
500+
Device companies
87
Toolkits sold
4.9/5
Customer rating
💡

Save more with the Complete Suite

98 toolkits × $247 avg = $3,705+ value → Get everything for just $997

Save ${Math.max(0, product.price * 15 - 997)} — View Bundle →

What's Inside

6 templates, SOPs, and checklists
ready to customize
Built from analysis
of real FDA 483 observations
Average implementation: 2–3 days
(vs. 4–6 weeks with a consultant)
Biological Evaluation Plan Template (ISO 10993-1:2018)
Toxicological Risk Assessment (TRA) Report Template
Chemical Characterization Report Structure Template (ISO 10993-18)
Biocompatibility Test Selection Justification Template
Biological Evaluation Report (BER) Summary Template
FDA Biocompatibility Submission Checklist (510k and PMA)
FREE BONUSES

Plus You'll Get These Bonuses Free

$47 Value

FDA Inspection Readiness Checklist

27-point checklist based on real 483 observations

$97/year Value

Quarterly Regulatory Updates

Free updates when FDA guidance changes

$29 Value

Implementation Quick-Start Guide

Step-by-step instructions to deploy templates in your QMS

Total Bonus Value: $173+ — Yours FREE with purchase

Benefits

BEP template aligned with FDA 2023 Use of ISO 10993-1 guidance
TRA template integrates chemical characterization data for testing alternative pathway
Test selection justification documents each ISO 10993-1 Table A.1 endpoint decision
BER summary integrates all evaluation components in FDA submission format

What QA/RA Professionals Say

Join 500+ medical device companies using RegWatchDaily templates

These templates saved us months of work. We passed our FDA inspection on the first try.

Sarah M.
QA Director, Class II Orthopedic Company
50-person manufacturer

Finally, templates that actually reflect how FDA inspectors think. Worth every penny.

Michael T.
RA Manager, Contract Manufacturer
ISO 13485 certified

We've used consultant templates before. These are better — more practical, less fluff.

Jennifer L.
VP Quality, Startup
Series A medical device company

Is This For You?

This toolkit is designed for teams facing these challenges:

FDA AI request citing biocompatibility documentation gaps in 510k submission
Chemical characterization data exists but TRA not documented to support testing alternative
Test selection rationale missing for exempted endpoints
BER summary not structured for FDA reviewer expectations

Who This Is For

Biocompatibility scientists preparing ISO 10993 evaluation packagesRA leads compiling biocompatibility documentation for 510k or PMA submissionsMaterials engineers conducting device material characterizationRegulatory consultants supporting biocompatibility strategy for novel materials

The Audit-Ready Guarantee

Try the toolkit for 7 full days. If you don't feel more confident about your next FDA inspection, email us and we'll refund every penny — no questions asked. You keep the templates.

Your investment is 100% protected.

Frequently Asked Questions

When can chemical characterization replace biocompatibility testing?

When chemical characterization demonstrates extractables below the analytical threshold or TRA confirms they are below tolerable intake. FDA 2023 guidance provides the framework for this determination.

Which ISO 10993 edition does FDA currently accept?

FDA aligns with ISO 10993-1:2018 per its 2023 guidance. Both the testing approach and chemical characterization plus TRA approach are accepted.

What file format are the templates in?

All templates are provided in editable Microsoft Word (.docx) format. You can customize them to match your company's branding and specific requirements.

How quickly will I receive the files?

Instantly. After purchase, you'll receive an email with download links within 2-3 minutes. Check your spam folder if you don't see it.

Can I use these for multiple projects or clients?

Yes. Your purchase includes a company-wide license. Use the templates across all your projects and devices within your organization.

Do these templates get updated when regulations change?

Yes. You'll receive free updates via email whenever we update templates for new guidance or regulatory changes.

What if I need help customizing the templates?

Email us at support@regwatchdaily.com. We typically respond within 24 hours with guidance on customization.

Is there a money-back guarantee?

Yes — the Audit-Ready Guarantee. If you're not satisfied within 7 days, email us for a full refund. No questions asked.

Ready to Get Audit-Ready?

Biocompatibility & TRA$347
+ FDA Inspection Readiness Checklist$47
+ Quarterly Regulatory Updates$97/year
+ Implementation Quick-Start Guide$29
Total Value$520+
Your Price Today$347
🛡️

7-Day Iron-Clad Guarantee

Download everything. Review every template. If it doesn't save you at least 40 hours of documentation work, email us for a full refund. No questions. No hassle.

Get Instant Access — $347

Every week without proper documentation is another week of audit exposure.

Secure checkoutInstant download7-day guarantee
Not quite ready? See smaller options →